1. Cell Cycle/DNA Damage PI3K/Akt/mTOR Membrane Transporter/Ion Channel
  2. DNA-PK BCRP
  3. Nedisertib

Nedisertib  (Synonyms: Peposertib; M3814)

目录号: HY-101570G
产品使用指南 技术支持

Nedisertib (GMP) (Peposertib (GMP)) 是 GMP 级别的 Nedisertib (HY-101570)。GMP 级别的小分子可用做细胞疗法中的辅助试剂。Nedisertib (Peposertib) 是一种口服有效的选择性 DNA 依赖性蛋白激酶 (DNA-PK) 抑制剂,IC50 值小于 3 nM。Nedisertib 也是 ABCG2 的调节剂,可逆转 ABCG2 介导的多药耐药 (MDR),为联合用药提供新策略。Nedisertib 可通过抑制 DNA 双链断裂修复增强化疗或放疗效果。Nedisertib 具有抗肿瘤的活性。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

Nedisertib

Nedisertib Chemical Structure

CAS No. : 1637542-33-6

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Nedisertib (GMP) (Peposertib (GMP)) is Nedisertib (HY-101570) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Nedisertib is an orally active selective DNA-dependent protein kinase (DNA-PK) inhibitor with an IC50 value of less than 3 nM. Nedisertib also acts as a modulator of ABCG2, capable of reversing ABCG2-mediated multidrug resistance (MDR), thus providing new strategies for combination therapy. By inhibiting DNA double-strand break repair, Nedisertib can enhance the efficacy of chemotherapy and radiotherapy. Nedisertib exhibits antitumor activity[1][2][3].

体外研究
(In Vitro)

Nedisertib (GMP) (0.3-1 µM; 72 h) 在 ABCG2 过表达的肺癌细胞系 NCI-H460/MX20 和 A549/MX10 中可显著增强 ABCG2 底物药物Mitoxantrone (HY-13502) 和 Doxorubicin (HY-15142A) 的细胞毒性,逆转多药耐药[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Nedisertib (GMP) (25-300 mg/kg; 口服; 单剂量) 在多种异种移植肿瘤模型中,增强了电离辐射的抗肿瘤效果[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 6 human xenograft models (HCT116, FaDu, NCI-H460, A549, Capan-1, BxPC3) in mice representing 4 different cancer types (colon, head and neck, lung, and pancreas) treated ionizing radiation (IR)[2]
Dosage: 25-300 mg/kg
Administration: Oral administration; single dose; 10 min prior to IR
Result: Significantly inhibited tumor growth in all 6 models in combination with IR.
Induced tumor regression in FaDu and NCI-H460 models, and showed no tumor regrowth in the FaDu model with the combination of 25 and 50 mg/kg and IR (total 60 Gy).
Had no significant weight loss or visual signs of toxicity in mice.
分子量

481.91

Formula

C24H21ClFN5O3

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Nedisertib
目录号:
HY-101570G
需求量: